 The FDA has approved Eli Lilly's Alzheimer drug, Denonimab, for adults in early stages of the disease. The treatment will be sold under the brand name Kisunla. Alzheimer's is the fifth leading cause of death for adults over the age of 65. Forget smartphones. Retailers are seeing an increase in sales for dumb phones that only have basic features to get away from social media. The simplistic trend is driven by concerns that excessive screen usage can have a negative impact on mental health.